Mutations of the beta-catenin encoding gene (CTNNB1) were identified with approximately 85% of sporadic tumors by Sanger sequencing, previously7, but next-generation sequencing estimates that these mutations may account for 90–95% of desmoid tumor cases8. Here, CTNNB1 is linked to desmoid tumor.